“I knew I would benefit from the treatment, and that made it less difficult to bear.”
Prompted by a family history of breast cancer, Anne Marie, an Irish medical scientist, scheduled a mammogram at the age of 47. She soon received the unwelcome news that she had early-stage breast cancer. "The diagnosis literally took my breath away," Anne Marie stated. Her oncologist advised radiotherapy, but chemotherapy remained a question. After learning about the Oncotype DX test, she enrolled in the TAILORx clinical trial, through which she and her physician gained access to additional information to help determine if she would benefit from chemotherapy. When she learned that she had a high Recurrence Score result, she felt resigned but determined. "I knew I would benefit from the treatment, and that made it less difficult to bear. I feel fortunate that I was one of the first patients in Ireland to get the test, which is now covered by the Irish public health care system and is helping patients around the world make more informed treatment decisions."
Back to Featured Stories